{"id":11627,"date":"2026-10-28T13:48:31","date_gmt":"2026-10-28T10:48:31","guid":{"rendered":"https:\/\/www.ortaakarsu.net\/?ism_drug=cannabidiol-kannabidiol"},"modified":"2026-10-28T13:48:44","modified_gmt":"2026-10-28T10:48:44","slug":"cannabidiol-kannabidiol","status":"publish","type":"ism_drug","link":"https:\/\/www.ortaakarsu.net\/?ism_drug=cannabidiol-kannabidiol","title":{"rendered":"Cannabidiol (Kannabidiol)"},"content":{"rendered":"<p><strong>Cannabidiol (Kannabidiol)<\/strong>, Kannabidiol etken maddesinin uluslararas\u0131 ad\u0131 \u00fczerinden haz\u0131rlanm\u0131\u015f bilgi sayfas\u0131d\u0131r.<\/p>\n<p><strong>Uygulama kapsam\u0131:<\/strong> A\u011f\u0131zdan; verilen oral enjekt\u00f6rle \u00f6l\u00e7\u00fcl\u00fcr. Besinler d\u00fczeyi de\u011fi\u015ftirebildi\u011finden yemekle veya yemeksiz kullan\u0131m\u0131n tutarl\u0131 olmas\u0131 gerekir. T\u00fcp ile uygulama gerekiyorsa \u00fcr\u00fcn\u00fcn \u00f6zel talimat\u0131 sa\u011fl\u0131k ekibince izlenir. Farkl\u0131 g\u00fc\u00e7 ve farmas\u00f6tik formlar\u0131n birbirinin yerine kullan\u0131labilece\u011fi varsay\u0131lmamal\u0131d\u0131r.<\/p>\n<h2>T\u00fcrkiye\u2019de yurt d\u0131\u015f\u0131ndan temin kayd\u0131<\/h2>\n<p><a href=\"https:\/\/www.teb.org.tr\/docs\/3aac322e-7bec-4df1-a37f-0dd1757bed11\/yurtdisi-aktif-ilac-listesi\" rel=\"noopener\">TEB\u2019in 2 Ekim 2026 tarihli \u00fcr\u00fcn listesinde<\/a> bu etken maddeyi i\u00e7eren \u00fcr\u00fcn kay\u0131tlar\u0131 do\u011fruland\u0131: EPIDYOLEX 100 MG\/ML 100 ML ORAL SOLUTION. <a href=\"https:\/\/www.titck.gov.tr\/dinamikmodul\/126\" rel=\"noopener\">T\u0130TCK\u2019nin 28 Eyl\u00fcl 2026 tarihli etken madde listesi<\/a> ayr\u0131ca kontrol edildi. Temin ko\u015fullar\u0131 hastaya, re\u00e7eteye, endikasyona ve gerekli onaylara g\u00f6re de\u011fi\u015febilir; listede yer almak g\u00fcncel stok veya geri \u00f6deme garantisi de\u011fildir. Klinik kullan\u0131m alan\u0131 a\u015fa\u011f\u0131daki \u00fcr\u00fcn belgesine g\u00f6re a\u00e7\u0131klan\u0131r; temin listesindeki tan\u0131 ko\u015fullar\u0131 tek ba\u015f\u0131na yeni bir klinik endikasyon olu\u015fturmaz.<\/p>\n<h2>Kaynaklar<\/h2>\n<ul>\n<li><a href=\"https:\/\/www.medicines.org.uk\/emc\/product\/10781\/smpc\" rel=\"noopener\">Jazz Pharmaceuticals UK EPIDYOLEX SmPC; metin 08.06.2026<\/a> (Jazz Pharmaceuticals UK EPIDYOLEX SmPC; metin 08.06.2026)<\/li>\n<li><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39601108\/\" rel=\"noopener\">A Phase I Trial of the Pharmacokinetic Interaction Between Cannabidiol and Tacrolimus<\/a> \u2014 So GC; Lu JBL; Koyama S; Cheng YH; Gisch DL; McClara K; Dexter PR; Sharfuddin AA; Etkins J; Tillman EM; Beamon TR; Cowsert Z; Stuart JS; Desta Z; Eadon MT; Clinical Pharmacology and Therapeutics; 2025; DOI: 10.1002\/cpt.3504<\/li>\n<li><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32652616\/\" rel=\"noopener\">A Phase 2, Double-Blind, Placebo-Controlled Trial to Investigate Potential Drug-Drug Interactions Between Cannabidiol and Clobazam<\/a> \u2014 VanLandingham KE; Crockett J; Taylor L; Morrison G; Journal of Clinical Pharmacology; 2020; DOI: 10.1002\/jcph.1634<\/li>\n<li><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30791225\/\" rel=\"noopener\">A Phase 1, Open-Label, Pharmacokinetic Trial to Investigate Possible Drug-Drug Interactions Between Clobazam, Stiripentol, or Valproate and Cannabidiol in Healthy Subjects<\/a> \u2014 Morrison G; Crockett J; Blakey G; Sommerville K; Clinical Pharmacology in Drug Development; 2019; DOI: 10.1002\/cpdd.665<\/li>\n<\/ul>\n<p>Kaynak kontrol\u00fc: <time datetime=\"2026-10-28\">28 Ekim 2026<\/time>. Bu tarih, bir hekim veya eczac\u0131 taraf\u0131ndan klinik inceleme yap\u0131ld\u0131\u011f\u0131 anlam\u0131na gelmez. Ki\u015fisel tedavi plan\u0131 i\u00e7in kullan\u0131lan \u00fcr\u00fcn\u00fcn g\u00fcncel talimat\u0131 ve sa\u011fl\u0131k uzman\u0131n\u0131n de\u011ferlendirmesi esas al\u0131n\u0131r.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cannabidiol (Kannabidiol), Kannabidiol etken maddesinin uluslararas\u0131 ad\u0131 \u00fczerinden haz\u0131rlanm\u0131\u015f bilgi  [&#8230;]<\/p>\n","protected":false},"featured_media":0,"template":"","ism_etken_madde":[1264],"class_list":["post-11627","ism_drug","type-ism_drug","status-publish","hentry","ism_etken_madde-kannabidiol"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.ortaakarsu.net\/index.php?rest_route=\/wp\/v2\/ism_drug\/11627","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ortaakarsu.net\/index.php?rest_route=\/wp\/v2\/ism_drug"}],"about":[{"href":"https:\/\/www.ortaakarsu.net\/index.php?rest_route=\/wp\/v2\/types\/ism_drug"}],"version-history":[{"count":1,"href":"https:\/\/www.ortaakarsu.net\/index.php?rest_route=\/wp\/v2\/ism_drug\/11627\/revisions"}],"predecessor-version":[{"id":11628,"href":"https:\/\/www.ortaakarsu.net\/index.php?rest_route=\/wp\/v2\/ism_drug\/11627\/revisions\/11628"}],"wp:attachment":[{"href":"https:\/\/www.ortaakarsu.net\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=11627"}],"wp:term":[{"taxonomy":"ism_etken_madde","embeddable":true,"href":"https:\/\/www.ortaakarsu.net\/index.php?rest_route=%2Fwp%2Fv2%2Fism_etken_madde&post=11627"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}